Literature DB >> 8265255

Rapid identification of mycobacteria by the Gen-Probe Accuprobe system.

R Lumb1, J A Lanser, I S Lim.   

Abstract

Chemiluminescent acridinium ester-labelled (AE)-DNA probes (Gen-Probe, Inc., San Diego, Calif.) for the identification of Mycobacterium tuberculosis complex (MTBC) and the M. avium-M. intracellulare complex (MAC) were evaluated using 184 mycobacterial isolates cultured in BACTEC 12B vials (Becton Dickinson and Co., Towson, Md.). A 1.5 mL aliquot from BACTEC 12B vials containing acid-fast bacilli and a Growth Index of > 200 was concentrated 15-fold using a centrifugation step prior to performing the test procedure. When 184 mycobacterial isolates were tested (42MTBC/142 nontuberculous mycobacteria) using the AE-MTBC probe, there was 100% sensitivity and specificity when compared with conventional identification procedures. Criteria for using the AE-MAC probe were defined to optimize results whilst minimizing laboratory costs. Ninety-one (64%) of AE-MTBC probe negative isolates failed to meet selection criteria and were not tested. When 51 (36%) of the AE-MTBC-probe negative mycobacterial isolates were tested, the AE-MAC probe was found to be 88% sensitive and 100% specific. The non-isotopic Gen-Probe test is a rapid and practical alternative to current procedures for differentiation of mycobacteria.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8265255     DOI: 10.3109/00313029309066597

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  8 in total

1.  Comparison of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of mycobacteria using simplified protein extraction protocols.

Authors:  Cheryl A Mather; Sheila F Rivera; Susan M Butler-Wu
Journal:  J Clin Microbiol       Date:  2013-10-30       Impact factor: 5.948

2.  Effectiveness and cost of rapid and conventional laboratory methods for Mycobacterium tuberculosis screening.

Authors:  S J Heymann; T F Brewer; M Ettling
Journal:  Public Health Rep       Date:  1997 Nov-Dec       Impact factor: 2.792

3.  Comparison of Sample Preparation Methods, Instrumentation Platforms, and Contemporary Commercial Databases for Identification of Clinically Relevant Mycobacteria by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.

Authors:  Craig B Wilen; Allison R McMullen; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2015-05-13       Impact factor: 5.948

4.  Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Combined Species Identification and Drug Sensitivity Testing in Mycobacteria.

Authors:  Pieter-Jan Ceyssens; Karine Soetaert; Markus Timke; An Van den Bossche; Katrin Sparbier; Koen De Cremer; Markus Kostrzewa; Marijke Hendrickx; Vanessa Mathys
Journal:  J Clin Microbiol       Date:  2016-12-21       Impact factor: 5.948

5.  Novel real-time simultaneous amplification and testing method to accurately and rapidly detect Mycobacterium tuberculosis complex.

Authors:  Zhenling Cui; Yongzhong Wang; Liang Fang; Ruijuan Zheng; Xiaochen Huang; Xiaoqin Liu; Gang Zhang; Dongmei Rui; Jinliang Ju; Zhongyi Hu
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

6.  Multicenter evaluation of the Abbott LCx Mycobacterium tuberculosis ligase chain reaction assay.

Authors:  R Lumb; K Davies; D Dawson; R Gibb; T Gottlieb; C Kershaw; K Kociuba; G Nimmo; N Sangster; M Worthington; I Bastian
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

Review 7.  Forty Years of Molecular Diagnostics for Infectious Diseases.

Authors:  Jonathan E Schmitz; Charles W Stratton; David H Persing; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2022-07-19       Impact factor: 11.677

Review 8.  Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria.

Authors:  Betty A Forbes; Geraldine S Hall; Melissa B Miller; Susan M Novak; Marie-Claire Rowlinson; Max Salfinger; Akos Somoskövi; David M Warshauer; Michael L Wilson
Journal:  Clin Microbiol Rev       Date:  2018-01-31       Impact factor: 26.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.